Log in/New account
CS
FD 2019/3 obr4

Cardiorenal syndrome and gliflozins

18. 12. 2019 Source: Forum Diabetologicum | 3/2019
FD 2019/3 obr6

Obesity, diabetes mellitus and cardiovascular disease: dangerous metabolic triad

18. 12. 2019 Source: Forum Diabetologicum | 3/2019
FD 2019/3 obr14

The EMPRISE study (Real World Evidence): empagliflozin is reducing number of hospitalizations for heart failure, even in patients without cardiovascular disease

18. 12. 2019 Source: Forum Diabetologicum | 3/2019
FD 2019/3 obr15

Cardiovascular studies and gliflozins

18. 12. 2019 Source: Forum Diabetologicum | 3/2019
Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account